| Landscape of tumor mutation load, mismatch repair deficiency, and PD-L1 expression in a large patient cohort of gastrointestinal cancers ME Salem, A Puccini, A Grothey, D Raghavan, RM Goldberg, J Xiu, ... Molecular Cancer Research 16 (5), 805-812, 2018 | 216 | 2018 |
| Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers ME Salem, BA Weinberg, J Xiu, WS El-Deiry, JJ Hwang, Z Gatalica, ... Oncotarget 8 (49), 86356, 2017 | 185 | 2017 |
| Characteristics of early-onset vs late-onset colorectal cancer: a review R Collaborative, AM Zaborowski, A Abdile, M Adamina, F Aigner, ... JAMA surgery 156 (9), 865-874, 2021 | 155 | 2021 |
| The growing challenge of young adults with colorectal cancer. BA Weinberg, JL Marshall, ME Salem Oncology (Williston Park, NY) 31 (5), 381-389, 2017 | 155 | 2017 |
| Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms S El-Chemaly, D Malide, E Zudaire, Y Ikeda, BA Weinberg, ... Proceedings of the National Academy of Sciences 106 (10), 3958-3963, 2009 | 133 | 2009 |
| Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets BA Weinberg, J Xiu, MR Lindberg, AF Shields, JJ Hwang, K Poorman, ... Journal of Gastrointestinal Oncology 10 (4), 652, 2019 | 130 | 2019 |
| Colon cancer in young adults: trends and their implications BA Weinberg, JL Marshall Current Oncology Reports 21, 1-7, 2019 | 113 | 2019 |
| Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma PA Philip, I Azar, J Xiu, MJ Hall, AE Hendifar, E Lou, JJ Hwang, J Gong, ... Clinical Cancer Research 28 (12), 2704-2714, 2022 | 79 | 2022 |
| Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancers K Mody, J Starr, M Saul, K Poorman, BA Weinberg, ME Salem, ... Journal of gastrointestinal oncology 10 (6), 1099, 2019 | 55 | 2019 |
| Efficacy and safety of zenocutuzumab in advanced pancreatic cancer and other solid tumors harboring NRG1 fusions AM Schram, E O’Reilly, G O’Kane J. Clin. Oncol 39 (3003), 10.1200, 2021 | 52 | 2021 |
| Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label … JH Strickler, A Cercek, S Siena, T André, K Ng, E Van Cutsem, C Wu, ... The Lancet Oncology 24 (5), 496-508, 2023 | 50 | 2023 |
| Efficacy and safety of zenocutuzumab, a HER2 x HER3 bispecific antibody, across advanced NRG1 fusion (NRG1+) cancers. AM Schram, K Goto, DW Kim, P Martin-Romano, SHI Ou, GM O'Kane, ... Journal of Clinical Oncology 40 (16_suppl), 105-105, 2022 | 43 | 2022 |
| Impact of patient age on molecular alterations of left‐sided colorectal tumors A Puccini, HJ Lenz, JL Marshall, D Arguello, D Raghavan, WM Korn, ... The oncologist 24 (3), 319-326, 2019 | 43 | 2019 |
| Preliminary results from a phase 1/2 study of BDC-1001, a novel HER2 targeting TLR7/8 immune-stimulating antibody conjugate (ISAC), in patients (pts) with advanced HER2 … M Sharma, RD Carvajal, GJ Hanna, BT Li, KN Moore, MD Pegram, ... J Clin Oncol 39 (15_suppl), 2549, 2021 | 40 | 2021 |
| Therapeutic Potential of Afatinib in NRG1 Fusion‐Driven Solid Tumors: A Case Series J Cadranel, SV Liu, M Duruisseaux, E Branden, Y Goto, BA Weinberg, ... The oncologist 26 (1), 7-16, 2021 | 37 | 2021 |
| Circulating tumor cells: technologies and their clinical potential in cancer metastasis J Xiao, PR Pohlmann, C Isaacs, BA Weinberg, AR He, R Schlegel, ... Biomedicines 9 (9), 1111, 2021 | 36 | 2021 |
| The landscape of alterations in DNA damage response pathways in colorectal cancer H Arai, A Elliott, J Xiu, J Wang, F Battaglin, N Kawanishi, S Soni, W Zhang, ... Clinical cancer research 27 (11), 3234-3242, 2021 | 33 | 2021 |
| Immuno‐oncology biomarkers for gastric and gastroesophageal junction adenocarcinoma: why PD‐L1 testing may not be enough BA Weinberg, J Xiu, JJ Hwang, AF Shields, ME Salem, JL Marshall The Oncologist 23 (10), 1171-1177, 2018 | 30 | 2018 |
| A phase I/II study of veliparib (ABT-888) in combination with 5-fluorouracil and oxaliplatin in patients with metastatic pancreatic cancer MJ Pishvaian, H Wang, AR He, JJ Hwang, BG Smaglo, SS Kim, ... Clinical Cancer Research 26 (19), 5092-5101, 2020 | 29 | 2020 |
| Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study J Wang, J Xiu, A Farrell, Y Baca, H Arai, F Battaglin, N Kawanishi, S Soni, ... The Lancet Oncology 24 (2), 151-161, 2023 | 22 | 2023 |
